Page 40 - EndoProxy2012_final

endo | 100 Endo Boulevard | Chadds Ford, Pennsylvania 19317 34
Name and Principal Position Year Salary ($) Bonus ($)
Stock
Awards ($)(1)
Option
Awards ($)(1)
Non-Equity
Incentive Plan
Compensation
($)(2)
All Other
Compensation
($)(3) Total ($)
David P. Holveck
President and Chief Executive
Officer
2011 $ 1,063,667 $ - $ 3,528,008 $ 1,760,933 $ 1,869,120 $ 155,433 $ 8,377,161
2010 $ 875,000 $ - $ 2,374,507 $ 1,222,133 $ 1,984,500 $ 146,318 $ 6,602,458
2009 $ 833,333 $ - $ 979,998 $ 2,995,240 $ 739,200 $ 136,596 $ 5,684,367
Alan G. Levin (4)
Executive Vice President &
Chief Financial Officer
2011 $ 638,833 $ - $ 1,112,370 $ 555,231 $ 563,364 $ 21,103 $ 2,890,901
2010 $ 615,000 $ - $ 852,891 $ 438,969 $ 556,756 $ 23,837 $ 2,487,453
2009 $ 350,000 $ 225,000 $ 718,185 $ 691,692 $ 363,000 $ 12,435 $ 2,360,312
Julie H. McHugh (5)
Chief Operating Officer
2011 $ 555,833 $ - $ 1,070,030 $ 534,075 $ 475,776 $ 92,438 $ 2,728,152
2010 $ 425,599 $ - $ 334,364 $ 1,000,084 $ 465,129 $ 50,984 $ 2,276,160
Ivan P. Gergel, M.D.
Executive Vice President, Re-
search & Development & Chief
Scientific Officer
2011 $ 632,833 $ - $ 904,956 $ 451,683 $ 412,764 $ 113,314 $ 2,515,550
2010 $ 613,546 $ - $ 886,129 $ 456,077 $ 763,538 $ 136,923 $ 2,856,213
2009 $ 592,729 $ - $ 313,379 $ 944,996 $ 360,746 $ 1,018,658 $ 3,230,508
Caroline B. Manogue
Executive Vice President, Chief
Legal Officer & Secretary
2011 $ 526,667 $ - $ 797,306 $ 397,980 $ 438,075 $ 87,315 $ 2,247,343
2010 $ 454,833 $ - $ 519,708 $ 267,498 $ 414,414 $ 78,857 $ 1,735,310
2009 $ 423,404 $ - $ 215,204 $ 648,965 $ 235,950 $ 80,560 $ 1,604,083
1 The amounts shown in this column represent the grant date fair value for each executive’s awards under ASC 718. The
grant date fair value of the portion of our PSUs which are earned based on the Company’s net sales performance was
determined using the closing price of the Company’s stock on the grant date. The grant date fair value of the portion
of our PSUs which are earned based on the Company’s TSR performance was determined using a Monte-Carlo variant
valuation model, which considers a variety of potential future stock prices for Endo as well as our peer companies in a
selected market index. See further discussion of the provisions of our PSUs above in the “Performance Shares Units”
section above. See notes 13, 13 and 12 to our audited financial statements included in our 2011, 2010 and 2009 Annual
Reports on Form 10-K, respectively, for the assumptions we used in valuing and expensing these awards in accordance
with ASC 718.
2 The amounts shown in this column represent cash amounts earned pursuant to the Company’s IC program with re-
spect to 2011, 2010 and 2009 performance, respectively. These amounts were awarded by the Committee on February
22, 2012, February 23, 2011 and February 19, 2010, respectively.
3 The amounts shown in this column for 2011 include the items summarized in the table below:
Compensation of Executive Officers and Directors
Summary Compensation Table
The following table sets forth the cash and non-cash compensation paid to or earned by our President and Chief Executive
Officer, Executive Vice President & Chief Financial Officer and the other three most highly compensated executive officers
of the Company (collectively, the NEOs) for the years ending December 31, 2011, 2010 and 2009. For a complete under-
standing of the table, please read the footnotes and narrative disclosures that follow the table.
Name and Principal
Position
Perquisites
& Other
Personal
Benefits (a)
Registrant
Contributions
to Defined
Contribution
Plans (b)
Life
Insurance
Premiums (c)
Tax
Reimbursements
(d) Other Total
David P. Holveck $ 10,000 $ 123,355 $ 15,408 $ 6,670 $ - $ 155,433
Alan G. Levin $ 3,698 $ 14,700 $ 2,705 $ - $ - $ 21,103
Julie H. McHugh $ 29,920 $ 61,258 $ 1,260 $ - $ - $ 92,438
Ivan P. Gergel, M.D. $ 18,995 $ 83,782 $ 3,122 $ 7,415 $ - $ 113,314
Caroline B. Manogue $ 20,652 $ 56,465 $ 1,100 $ 9,098 $ - $ 87,315
a Mr. Holveck received $10,000 for financial planning services. Mr. Levin received $3,698 for travel allowance. Ms.
McHugh received $21,600 for car allowance and related costs and $8,320 for financial planning services. Dr. Ger-
gel received $12,122 for car allowance and related costs, $4,572 for financial planning services and $2,301 for
relocation expenses. Ms. Manogue received $9,553 for car allowance and related costs and $11,099 for financial
planning services.
b Represents the employers’ matching contribution to the Company’s Savings and Investment (401(k)) Plan and the
Parity Plan.
c Represents annual premiums paid by the Company for executive term life insurance policies.